CYTORI THERAPEUTICS, INC DEF 14A 07_02_2015

Company

PLUS THERAPEUTICS, INC.

Filed

July 2, 2015

Period of Report

July 2, 2015

Accession Number

0001095981-15-000024

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →